Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
Craig-Hallum Downgrades Agilysys to Hold, Announces $50 Price Target
Craig-Hallum analyst George Sutton downgrades Agilysys (NASDAQ:AGYS) from Buy to Hold and announces $50 price target.
Earnings Outlook For Agilysys
Agilysys (NASDAQ:AGYS) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement.
Analysts estimate that Agilysys will report an earnings per share (EPS) of $0.18.
Why Is Agilysys Stock Rising After Hours?
Agilysys Inc (NASDAQ: AGYS) shares are trading higher in Tuesday's after-hours session after the company reported better-than-expected financial results and issued guidance above analyst estimates.
Agilysys: Q4 Earnings Insights
Agilysys (NASDAQ:AGYS) reported its Q4 earnings results on Tuesday, May 17, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Agilysys beat estimated earnings by 41.18%, reporting an EPS of $0.24 versus an estimate of $0.17.